| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.3M | $71.9K | $188.0K |
| YoY Revenue Growth % | +17054.9% | -61.8% | — |
| Gross Profit | $5.5M | $48.0M | — |
| Gross Margin % | 44.4% | 98.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$96.6M | -$12.9M | -$21.9M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$101.2M | -$14.5M | -$26.5M |
| EBITDA (Normalized) | -$96.6M | -$12.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$3.7M | -$15.1M | -$15.8M |
| Capital Expenditures (CapEx) | $41.7K | $368.2K | — |
| Free Cash Flow (FCF) | -$3.7M | -$15.5M | -$15.8M |
| FCF Margin % | -30.3% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $2.3M | $846.6K | — |
| Total Debt (Short + Long Term) | $1.4M | — | — |
| Total Stockholders' Equity | -$100.6M | -$12.2M | — |